Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

HDAC Inhibitors: New Promise in the Treatment of Immune and Inflammatory Disease

The development of HDAC inhibitors (HDAC-Is) has emerged as an important strategy in the design of new drugs to treat cancer, but more recently they have also found application in the treatment of immune and inflammatory diseases.

By Stephen Shuttleworth and Simon Kerry at Karus Therapeutics Ltd (March 2009)

Keywords: Rheumatoid Arthritis, Novel anti-inflammatory HDAC-Is

    View full article    |    Back to Discovery Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |